Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital
2024

Impact of Treatment on Children with Carbapenem-Resistant Infections

Sample size: 114 publication 10 minutes Evidence: moderate

Author Information

Author(s): Avcu Gulhadiye, Erci Ece, Bilen Nimet Melis, Ersayoglu Irem, Ozek Gulcihan, Celtik Ulgen, Terek Demet, Cilli Feriha, Bal Zumrut Sahbudak

Primary Institution: Ege University, Izmir, Turkey

Hypothesis

What are the risk factors and outcomes for children with carbapenem-resistant Enterobacteriaceae bloodstream infections?

Conclusion

The study found a high mortality rate among children with CRE bloodstream infections, with catheter removal significantly lowering mortality rates.

Supporting Evidence

  • 14% of the children with CRE-BSIs died within 30 days.
  • Previous PICU admission and inotropic support were significant predictors of mortality.
  • Removing central venous catheters was associated with lower mortality rates.

Takeaway

This study looked at sick kids with a tough infection and found that taking out their catheters helped them get better.

Methodology

The study analyzed medical records of hospitalized children diagnosed with CRE bloodstream infections from January 2018 to December 2022.

Potential Biases

Potential bias due to the retrospective nature and reliance on medical records.

Limitations

The study is retrospective and conducted at a single center, limiting generalizability.

Participant Demographics

Median age of participants was 11 months, with 66.6% male and all having at least one underlying comorbidity.

Statistical Information

P-Value

0.01

Confidence Interval

95% CI: 1.741–94.137

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1093/jac/dkae387

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication